BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1091119)

  • 1. Studies on the mechanism of somatostatin action on insulin release in man. I. Effect of blockade of alpha-adrenergic receptors.
    Efendić S; Luft R
    Acta Endocrinol (Copenh); 1975 Mar; 78(3):516-23. PubMed ID: 1091119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the inhibitory effect of somatostatin on glucose induced insulin release in the isolated perfused rat pancreas.
    Efendić S; Luft R
    Acta Endocrinol (Copenh); 1975 Mar; 78(3):510-5. PubMed ID: 1091118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phentolamine blocks the somatostatin-mediated inhibition of insulin secretion.
    Smith PH; Woods SC; Porte D
    Endocrinology; 1976 Apr; 98(4):1073-6. PubMed ID: 776596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of growth hormone-releasing hormone stimulation of the endocrine pancreas: studies with alpha- and beta-adrenergic and cholinergic antagonists.
    Hermansen K; Kappelgaard AM
    Acta Endocrinol (Copenh); 1987 Apr; 114(4):589-94. PubMed ID: 2883798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin: hypothalamic inhibitor of the endocrine pancreas.
    Koerker DJ; Ruch W; Chideckel E; Palmer J; Goodner CJ; Ensinck J; Gale CC
    Science; 1974 Apr; 184(4135):482-4. PubMed ID: 4594711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of somatostatin on glucose induced insulin release in isolated perfused rat pancreas and isolated rat pancreatic islets.
    Efendic S; Luft R; Grill V
    FEBS Lett; 1974 Jun; 42(2):169-72. PubMed ID: 4368634
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct inhibition of insulin secretion by synthetic somatostatin.
    Curry DL; Bennett LL; Li CH
    Biochem Biophys Res Commun; 1974 Jun; 58(3):885-9. PubMed ID: 4599685
    [No Abstract]   [Full Text] [Related]  

  • 10. Adrenergic receptors and the secretion of glucagon and insulin from the isolated, perfused canine pancreas.
    Iversen J
    J Clin Invest; 1973 Sep; 52(9):2102-16. PubMed ID: 4727451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diazoxide effects on biphasic insulin release: "adrenergic" suppression and enhancement in the perifused rat pancreas.
    Burr IM; Marliss EB; Stauffacher W; Renold AE
    J Clin Invest; 1971 Jul; 50(7):1444-50. PubMed ID: 5090060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanism for regulation of insulin release in hypoxia.
    Baum D; Porte D
    Am J Physiol; 1972 Mar; 222(3):695-9. PubMed ID: 4401851
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory effect of somatostatin on insulin secretion during alpha-adrenergic blockade in three different species.
    Järhult J; Ahrén B; Lundquist I
    Acta Endocrinol (Copenh); 1979 Sep; 92(1):166-73. PubMed ID: 386685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phentolamine and the action of somatostatin in man.
    Schmitt JK; Lorenzi M; Gerich JE; Bohannon NV; Karam JH; Forsham PH
    J Clin Endocrinol Metab; 1979 May; 48(5):880-2. PubMed ID: 219013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of galanin on growth hormone-releasing factor and somatostatin release from median eminence fragments in vitro.
    Aguila MC; Marubayashi U; McCann SM
    Neuroendocrinology; 1992 Dec; 56(6):889-94. PubMed ID: 1285434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mode of action of somatostatin on insulin secretion.
    Basabe JC; Cresto JC; Aparicio N
    Endocrinology; 1977 Nov; 101(5):1436-43. PubMed ID: 199419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenergic modulation of basal insulin secretion in man.
    Robertson RP; Porte D
    Diabetes; 1973 Jan; 22(1):1-8. PubMed ID: 4683792
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the mechanism of action of somatostatin on the endocrine pancreas. I. Interaction with alpha-adrenergic receptors.
    Hara M; Patton GS; Gerich JE
    Endocrinology; 1979 Sep; 105(3):801-5. PubMed ID: 223833
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta adrenergic receptor dysfunction in hypoxic inhibition of insulin release.
    Baum D; Porte D
    Endocrinology; 1976 Feb; 98(2):359-66. PubMed ID: 1248452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic receptor control mechanism for growth hormone secretion.
    Blackard WG; Heidingsfelder SA
    J Clin Invest; 1968 Jun; 47(6):1407-14. PubMed ID: 5653218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.